How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/xerostomia-secondary-to-sjogren-s-syndrome.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Xerostomia Secondary to Sjogren's Syndrome — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Xerostomia Secondary to Sjogren's Syndrome (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Xerostomia Secondary to Sjogren's Syndrome, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Evoxac	CEVIMELINE	Cosette	Cholinergic Receptor Agonist	Muscarinic acetylcholine receptor M1		2000-01-01
Salagen	Salagen	Alberta Health services		Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Xerostomia Secondary to Sjogren's Syndrome
Alberta Health services · 1 drug in Xerostomia Secondary to Sjogren's Syndrome
Cosette · 1 drug in Xerostomia Secondary to Sjogren's Syndrome

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Xerostomia Secondary to Sjogren's Syndrome:

Cite this brief

Drug Landscape (2026). Xerostomia Secondary to Sjogren's Syndrome — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/xerostomia-secondary-to-sjogren-s-syndrome. Accessed 2026-06-10.

Xerostomia Secondary to Sjogren's Syndrome full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing